Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years

Completed

• Conditions: Atrial Fibrillation

• Registration Number: NCT02894450
• Lead Sponsor: Nantes University Hospital

Brief Summary

The objective of this study was to investigate whether there is a link between clinical and biological variables and bioassay high xaban in elderly patients as part of an unscheduled hospitalization.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-12
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Study First Submitted: 2016-08-11
• Status Verified: 2016-09
• Study First Submitted QC: 2016-09-08
• Last Update Submitted: 2016-09-08
• Study First Posted: 2016-09-09
• Last Update Posted: 2016-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• Age ≥ 75 years
• Entering SAU or MPG (Nantes University Hospital) as part of an unscheduled hospitalization for acute or subacute disease (About MPG, will be included patients admitted to the department within 48 hours of calling the doctor)
• In xaban to entry (dabigatran, rivaroxaban, Apixaban) for non-valvular atrial fibrillation
• In whom hemostasis tests will be prescribed as part of usual care
• Patient has given its verbal agreement

Exclusion criteria

Patients with the following criteria may not be included:

• Patients refusing to participate in the study
• Patients under guardianship
• Inability to obtain the date and time of the last dose of xaban

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
bioassay direct oral anticoagulants	Baseline